Our projects

Field-testing moxidectin for river blindness controlThe EMINENCE project is exploring whether a newly developed drug, moxidectin, could accelerate the elimination of onchocerciasis (river...

Advancing monoclonal antibodies to treat HIV in infantsThe ENABLE project is assessing whether broadly neutralising antibodies could make the HIV virus undetectable in young infants.

Automating parasite egg detectionThe DIDIDI project is developing automated systems and AI tools to provide a more rapid assessment of parasitic worm burdens.

Protecting contacts of Bundibugyo patientsThe EBO-PEP 2026 project is assessing whether an antiviral can prevent disease in individuals who have had close contact with patients with Ebola...

Standardised tracking of malaria and tuberculosis drug resistance The PANGenS project will introduce standardised approaches for identifying malaria and TB genetic variants associated with...

Accelerating vaccine development for neglected tropical diseasesThe EAVI project is establishing an international partnership to promote the clinical testing of vaccines against neglected...

Monitoring mpox vaccine activity in AfricaThe MpoxVax AFRIVAC project is closing key knowledge gaps on the performance of mpox vaccines in Central Africa.

Building capacity in new drug developmentThe PACoPPDeT project is developing a cohort of researchers with a deep understanding of all aspects of pharmaceutical product development.

Extending ivermectin use to young childrenThe IVM-KIDS project is developing a child-friendly formulation of ivermectin to ensure young children can benefit from this key drug for parasite...

Repurposing fusidic acid for onchocerciasis controlThe FAME project is assessing whether a repurposed antibiotic could improve control of onchocerciasis (river blindness).

TB prevention in people living with diabetesThe EDCTP2-funded PROTID project has received additional Global Health EDCTP3 funding, enabling it to complete its trial of preventive TB...

Protecting antibiotic potencyThe ASPIRE project is assessing whether improved infection prevention and control, coupled with more personalised antibiotic use, can reduce pressures driving...

Targeting vectors for infection prediction and controlThe IMPACTING project is collecting data on a host of insect vectors that spread infections to help better predict the risk of...

Rapid testing of urinary tract infectionsThe UTI-Diag project is exploring whether point-of-care tests could improve detection and management of urinary tract infections (UTIs) and reduce...

Disrupting mosquito feeding to prevent malariaThe LASR project is testing whether a newly developed mosquito repellent can reduce the community burden of malaria infections.

Supporting women living with HIV after pregnancyThe DOLPHIN-3 project is assessing whether it is feasible to temporarily transfer women living with HIV from oral antiretroviral therapy (ART)...

Building modelling capacity to enhance disease controlThe IDM-AFRICA project is creating a training programme to strengthen capacity for infectious disease modelling in sub-Saharan Africa. 

Understanding mpox infections during pregnancyThe PREGMPOX project is attempting to find out why mpox virus infections are particularly harmful to pregnant women.

A point-of-care test for Bundibugyo virusThe EPOCA-BVD project is developing a sensitive point-of-care test for Bundibugyo virus, based on innovative new materials and biosensing technology.

Optimising HIV treatments for pregnant womenGlobal Health EDCTP3 funding will enable the EDCTP2-supported PREGART project to complete a key trial that will provide evidence on the optimal...